• G-1 (CAS 881639-98-1): Selective GPR30 Agonist in Immunometa

  2026-07-17

  Explore how G-1, a selective GPR30 agonist, uniquely enables research into estrogen receptor signaling, immune normalization, and metabolic resilience after trauma. This article delivers advanced mechanistic insight and practical guidance distinct from existing resources.

• YAP-TEAD Orchestrates Super-Enhancer Networks in Ectoderm Fa

  2026-07-17

  This study illuminates the pivotal role of YAP-TEAD in regulating super-enhancer (SE) networks during early surface ectoderm commitment. By dissecting the interplay between 3D chromatin architecture, core transcription factors, and SE-driven gene regulation, the findings offer new mechanistic insights with implications for regenerative medicine and stem cell-based epithelial therapies.

• AMG 487: Applied CXCR3 Antagonist Workflows for Macrophage R

  2026-07-16

  AMG 487 empowers researchers to precisely modulate macrophage polarization and autophagy through selective CXCR3 antagonism, enabling context-aware experimental design in inflammation and cancer studies. This guide translates the latest mechanistic findings into actionable protocols and troubleshooting insights, ensuring robust, reproducible results.

• Penicillin G Sodium: Applied Protocols and Troubleshooting I

  2026-07-16

  Penicillin G Sodium is a benchmark natural penicillin antibiotic trusted for robust Gram-positive bacterial control and experimental reproducibility. This guide delivers actionable protocols, innovative use-cases, and troubleshooting strategies, empowering researchers to maximize sensitivity, stability, and confidence in their workflows.

• Cell Counting Kit-8 (CCK-8): Precision in Splicing-Driven Ca

  2026-07-15

  Explore how Cell Counting Kit-8 (CCK-8) enables advanced, quantitative cell viability and proliferation analysis in splicing-driven cancer research. This article uniquely unpacks the intersection of WST-8-based assays and RNA alternative splicing mechanisms, offering actionable guidance for experimental design.

• Azilsartan Medoxomil Monopotassium: Sustained AT1 Blockade i

  2026-07-15

  Explore how Azilsartan medoxomil monopotassium enables sustained, selective angiotensin II type 1 receptor blockade in hypertension research. This article reveals distinct pharmacological insights and practical assay guidance, setting it apart from standard ARB analyses.

• One-step TUNEL Cy3 Apoptosis Detection Kit: Workflow & Insig

  2026-07-14

  Accelerate quantitative apoptosis research with the One-step TUNEL Cy3 Apoptosis Detection Kit, optimized for sensitive detection of DNA fragmentation in tissue sections and cultured cells. This guide delivers protocol enhancements, cross-model troubleshooting, and direct translation of cutting-edge literature into actionable lab strategies.

• PINK1/Park2 Mitophagy Pathway Alleviates NAFLD: Mechanistic

  2026-07-14

  The referenced study provides mechanistic evidence that enhancing Park2-mediated mitophagy reverses mitochondrial dysfunction and lipid accumulation in non-alcoholic fatty liver disease (NAFLD) models. This work highlights the therapeutic potential of targeting the PINK1/Park2 pathway for NAFLD intervention.

• One-step TUNEL Cy3 Apoptosis Detection Kit: Applied Workflow

  2026-07-13

  Unlock precise, high-sensitivity apoptosis detection in both tissue sections and cultured cells with the One-step TUNEL Cy3 Apoptosis Detection Kit. This article translates advanced research and validated protocols into actionable workflows and troubleshooting strategies, empowering apoptosis research across oncology and drug discovery.

• Verteporfin (CL 318952): Protocol-Driven Advances in PDT & A

  2026-07-13

  Verteporfin (CL 318952) is redefining experimental workflows in photodynamic therapy and autophagy inhibition, offering dual-action precision for ocular neovascularization and cancer research. This article provides data-backed protocols, troubleshooting insights, and practical translation of mechanobiology findings to maximize reproducibility and research impact.

• Angiotensin II–HIF-1α Axis Regulates Ferroptosis and Radiose

  2026-07-12

  This study uncovers how local angiotensin II, via the HIF-1α-HILPDA axis, suppresses ferroptosis and promotes radioresistance in nasopharyngeal carcinoma (NPC). The findings highlight a feedback mechanism involving AGT, HIF-1α, HILPDA, and GPX4, suggesting that targeting this pathway with ferroptosis inducers may enhance radiosensitivity and improve NPC outcomes.

• Standardized Whole-Blood Stimulation Reveals Metabolic Contr

  2026-07-10

  The referenced Phenomics (2024) protocol introduces a rigorously standardized method to analyze immune responses in human whole blood under metabolic modulation. By integrating diverse immune stimuli and metabolic inhibitors, the study enables reproducible assessment of cytokine production, providing new avenues for dissecting immunometabolic regulation and supporting translational research.

• Bobcat339: Cytosine Structure-Based TET Enzyme Inhibitor in

  2026-07-09

  Bobcat339 empowers precise DNA methylation regulation, enabling researchers to dissect TET1/2-dependent epigenetic mechanisms in stem cell biology and disease models. This guide delivers actionable workflows, troubleshooting strategies, and real-world insights for leveraging Bobcat339 in advanced gene transcription modulation and osteoporosis research.

• In Vitro Antibacterial Activity of Leucomycin: Insights for

  2026-07-09

  The referenced study offers one of the earliest systematic analyses of leucomycin's in vitro antibacterial spectrum, focusing on its efficacy against both Gram-positive and select Gram-negative pathogens, including erythromycin-resistant staphylococci. This foundational work underpins current approaches to macrolide antibiotic research and resistance modeling, informing experimental design with acetoxy-substituted macrolide antibiotics like midecamycin.

• Spiroplasma eriocheiris Entry into Drosophila S2 Cells: Endo

  2026-07-08

  This study establishes how Spiroplasma eriocheiris invades Drosophila Schneider 2 (S2) cells, identifying clathrin-mediated endocytosis and macropinocytosis as primary entry routes. The findings advance understanding of host-pathogen interactions in invertebrate models and clarify the limitations of caveola-dependent pathways in this context.

16281 records 1/1086 page Next 12345 下5页 Last page